You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨信達生物(1801.HK)站上100港元大關 向印尼科企授獨家許可
格隆匯 01-20 10:20
格隆匯1月20日丨信達生物(1801.HK)漲超6%,站上100港元大關報102.9港元,總市值1443.5億港元。信達生物宣佈與印尼生物科技公司PT Etana Biotechnologies就達攸同®️簽訂合作協議,信達生物向Etana授予達攸同®️印尼獨家許可,信達生物將獲得開發和銷售里程碑付款以及雙位數比例的淨銷售額提成。另外,信達生物首席財務官奚浩日前在一個論壇上表示,集團目前有23個研發藥品進入臨牀,包括治療免疫力問題及癌症等多個類別,並有4個藥品準備推出市場,未來會繼續聚焦於創新藥物研發。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account